Coagulation: Difference between revisions
Appearance
No edit summary |
No edit summary |
||
| Line 132: | Line 132: | ||
300ul citrate | 300ul citrate | ||
Coagulation Testing | |||
{| class="wikitable" | |||
|+ | |||
!Test | |||
!Test Method | |||
!Causes of Abnormal Results | |||
!RI | |||
|- | |||
|PT/INR (Prothrombin Time) | |||
| | |||
* Citrated PPP (platelet poor plasma) | |||
* Calcium thromboplastin added | |||
* Measured optically or mechanically | |||
** Optical: light scattered as fibrin strands form | |||
** Mechanical: magnetic balls oscillates, movement impeded by clot | |||
| | |||
|11.5-13.5s | |||
INR: 0.9-1.2 | |||
|- | |||
|APTT | |||
| | |||
* Citrated PPP mixed with APTT reagent | |||
* Activation of factor XII and XI | |||
* Calcium then added to activate factor IX and VIII | |||
* Factor X activated, causing cascade to activate Factor II and I, forming fibrin clot | |||
| | |||
|23-35 s | |||
|- | |||
|Fibrinogen (Clauss Assay) | |||
| | |||
* Clauss assay uses reference plasma samples with known concentrations of fibrinogen | |||
* Run thrombin time (high thrombin concentration) and plot results of concentration vs. time | |||
* Patient samples can then be run and compared to the curve to determine fibrinogen concentration | |||
| | |||
| | |||
|- | |||
|Thrombin Time | |||
| | |||
* Citrated PPP | |||
* Low concentration of thrombin added to cleave fibrinogen -> fibrin | |||
* Measure time to form fibrin clot | |||
| | |||
* Congential fibrinogen deficiencies | |||
* Acquired fibrinogen deficincies | |||
* Unfractionated heparin | |||
* Direct thrombin inhibitors (dabigatran, apixaban) | |||
| | |||
|- | |||
|Unfractionated Heparin/Anti-Xa Assay | |||
| | |||
| | |||
| | |||
|- | |||
|Factor Assays | |||
| | |||
| | |||
| | |||
|} | |||
Revision as of 18:39, 27 January 2025
Factors II, V, VIII, HMWK -> cofactors
Factors II, VII, 9-12, Prekallikrein -> serine proteases
Vitamin K Dependent Factors
- Serine Proteases
- Factors II, VII, IX, X
- Regulatory control proteins C, S, Z
| Factor | Other Names | Pathway(s) | Role | Location of Synthesis |
|---|---|---|---|---|
| I | Fibrinogen | Common | ||
| II | Prothrombin | Common | ||
| III | Tissue Factor (TF) | |||
| IV | Ca2+ | |||
| V | Labile factor | Common | ||
| VII | Stable factor | Extrinsic | ||
| VIII | Anti-hemophilic factor | Intrinsic | ||
| IX | Christmas Factor | Intrinsic | ||
| X | Stuart-Prower Factor | Common | ||
| XI | PTA (Plasma Thromboplastin Antecedent) | Intrinsic | ||
| XII | Hageman Factor | Intrinsic | ||
| XIII | Fibrin Stabilizing Factor (FSF) | Crosslinks adjacent fibrin strand D-domains to make an insoluble polymer | ||
| VWF | ||||
| HMWK | High Molecular Weight | |||
Stages of Hemostasis
- Primary hemostasis
- Secondary hemostasis
- Fibrin clot formation
- Coagulation inhibition
Protein Z
- Z-dependent protease inhibitor (ZPI)
- Protein Z enhances ZPI activity
- inhibits factor X and XI
Restoring Blood Flow
- Fibrinolytic proteins
- Plasminogen
- Converted into plasmin by TPA and UPA
- Plasmin helps restore blood flow
- TPA
- UPA
- Plasminogen
1.85*10^-3 x (100-HCT) x v
300ul citrate
Coagulation Testing
| Test | Test Method | Causes of Abnormal Results | RI |
|---|---|---|---|
| PT/INR (Prothrombin Time) |
|
11.5-13.5s
INR: 0.9-1.2 | |
| APTT |
|
23-35 s | |
| Fibrinogen (Clauss Assay) |
|
||
| Thrombin Time |
|
|
|
| Unfractionated Heparin/Anti-Xa Assay | |||
| Factor Assays |